FDA panel recommends testosterone therapy be more accessible to men

This is T-rrific news for some men.

Testosterone replacement therapy (TRT) has been historically difficult to get because it requires proof of consistently low testosterone levels along with symptoms like fatigue, low libido or erectile dysfunction that’s not just from aging .

Now, a US Food and Drug Administration panel is recommending loosening testosterone restrictions by declassifying these meds as controlled substances and updating their labels to expand access for men with age-related low testosterone.

“Testosterone deficiency negatively impacts health, reduces quality of life [and] increases the risk for mortality,” Dr. Mohit Khera , a professor of urology at Baylor College of Medicine, said at Wednesday’s panel discussion, per Urology Times .

“Testosterone therapy offers